EP 1044004 A1 20001018 - A2A ADENOSINE RECEPTOR AGONISTS IN COMBINATION WITH A TYPE IV PHOSPHODIESTERASE INHIBITORS
Title (en)
A2A ADENOSINE RECEPTOR AGONISTS IN COMBINATION WITH A TYPE IV PHOSPHODIESTERASE INHIBITORS
Title (de)
A2A ADENOSIN REZEPTOR AGONISTEN IN KOMBINATION MIT TYP IV PHOSPHODIESTERASE INHIBITOREN
Title (fr)
AGONISTES DE RECEPTEUR D'ADENOSINE A 2A?
Publication
Application
Priority
- US 9900366 W 19990107
- US 393098 A 19980108
Abstract (en)
[origin: WO9934804A1] Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of inflammatory diseases.
IPC 1-7
IPC 8 full level
A61K 31/52 (2006.01); A61K 31/7042 (2006.01); A61K 31/7052 (2006.01); A61K 31/7076 (2006.01); A61K 35/76 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07H 19/167 (2006.01)
CPC (source: EP)
A61K 31/40 (2013.01); A61K 31/52 (2013.01); A61K 31/70 (2013.01); A61K 45/06 (2013.01); A61P 29/00 (2017.12); A61P 43/00 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 9934804A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9934804 A1 19990715; AU 2108299 A 19990726; CA 2317093 A1 19990715; EP 1044004 A1 20001018; JP 2002500188 A 20020108
DOCDB simple family (application)
US 9900366 W 19990107; AU 2108299 A 19990107; CA 2317093 A 19990107; EP 99901368 A 19990107; JP 2000527253 A 19990107